| Primary | 
									
											
										
											| Diabetic Nephropathy | 37.5% |  
											| Hypertension | 27.5% |  
											| Product Used For Unknown Indication | 17.5% |  
											| Cerebrovascular Accident | 5.0% |  
											| Essential Hypertension | 5.0% |  
											| Off Label Use | 5.0% |  
											| Renal Failure | 2.5% |  | 
									
											
										
											| Nephrolithiasis | 10.0% |  
											| Weight Decreased | 10.0% |  
											| Alanine Aminotransferase Increased | 5.0% |  
											| Blood Pressure Decreased | 5.0% |  
											| Exposure During Pregnancy | 5.0% |  
											| Hyperkalaemia | 5.0% |  
											| Memory Impairment | 5.0% |  
											| Mycosis Fungoides | 5.0% |  
											| Myocardial Infarction | 5.0% |  
											| Orthostatic Hypotension | 5.0% |  
											| Premature Baby | 5.0% |  
											| Premature Rupture Of Membranes | 5.0% |  
											| Renal Impairment | 5.0% |  
											| Sinus Headache | 5.0% |  
											| Suicide Attempt | 5.0% |  
											| Transient Ischaemic Attack | 5.0% |  
											| Vestibular Disorder | 5.0% |  
											| Vomiting | 5.0% |  | 
							
						
							| Secondary | 
									
											
										
											| Product Used For Unknown Indication | 59.2% |  
											| Hypertension | 15.2% |  
											| Diabetic Nephropathy | 10.3% |  
											| Drug Use For Unknown Indication | 3.9% |  
											| Muscle Spasms | 2.0% |  
											| Rheumatoid Arthritis | 1.5% |  
											| Diabetes Mellitus | 1.2% |  
											| Blood Pressure Increased | 0.7% |  
											| Dyslipidaemia | 0.7% |  
											| Gout | 0.7% |  
											| Multiple Myeloma | 0.7% |  
											| Alcoholism | 0.5% |  
											| Back Pain | 0.5% |  
											| Hypersensitivity | 0.5% |  
											| Multiple Allergies | 0.5% |  
											| Sjogren's Syndrome | 0.5% |  
											| Type 2 Diabetes Mellitus | 0.5% |  
											| Arthritis | 0.2% |  
											| Benign Prostatic Hyperplasia | 0.2% |  
											| Bursitis | 0.2% |  | 
									
											
										
											| Vestibular Disorder | 15.0% |  
											| Death | 10.0% |  
											| Hyperkalaemia | 10.0% |  
											| Completed Suicide | 5.0% |  
											| Memory Impairment | 5.0% |  
											| Orthostatic Hypotension | 5.0% |  
											| Renal Failure Acute | 5.0% |  
											| Rhabdomyolysis | 5.0% |  
											| Sudden Death | 5.0% |  
											| Toxicity To Various Agents | 5.0% |  
											| Transient Ischaemic Attack | 5.0% |  
											| Vomiting | 5.0% |  
											| Alanine Aminotransferase Increased | 2.5% |  
											| Infarction | 2.5% |  
											| Interstitial Lung Disease | 2.5% |  
											| Mesenteric Artery Stenosis | 2.5% |  
											| Multiple Fractures | 2.5% |  
											| Myopathy | 2.5% |  
											| Organ Failure | 2.5% |  
											| Poisoning | 2.5% |  | 
							
						
							| Concomitant | 
									
											
										
											| Hypertension | 29.2% |  
											| Product Used For Unknown Indication | 13.7% |  
											| Drug Use For Unknown Indication | 12.3% |  
											| Rheumatoid Arthritis | 5.3% |  
											| Atrial Fibrillation | 5.0% |  
											| Pain | 3.8% |  
											| Diabetes Mellitus | 3.2% |  
											| Prostate Cancer | 3.2% |  
											| Prophylaxis | 3.0% |  
											| Hypercholesterolaemia | 2.9% |  
											| Major Depression | 2.9% |  
											| Depression | 2.1% |  
											| Acute Myocardial Infarction | 1.8% |  
											| Blood Cholesterol Increased | 1.8% |  
											| Coronary Artery Disease | 1.8% |  
											| Hypothyroidism | 1.8% |  
											| Back Pain | 1.6% |  
											| Benign Prostatic Hyperplasia | 1.6% |  
											| Essential Hypertension | 1.6% |  
											| Schizophrenia | 1.6% |  | 
									
											
										
											| Speech Disorder | 9.8% |  
											| Renal Failure Acute | 7.3% |  
											| Urinary Tract Infection | 7.3% |  
											| Renal Failure | 6.1% |  
											| Weight Increased | 6.1% |  
											| Cholecystitis Acute | 4.9% |  
											| Hypertension | 4.9% |  
											| Hypertensive Crisis | 4.9% |  
											| Lower Respiratory Tract Infection | 4.9% |  
											| Malaise | 4.9% |  
											| Sleep Apnoea Syndrome | 4.9% |  
											| Vomiting | 4.9% |  
											| Hyponatraemia | 3.7% |  
											| Myocardial Infarction | 3.7% |  
											| Nausea | 3.7% |  
											| Oedema Peripheral | 3.7% |  
											| Pancreatitis Acute | 3.7% |  
											| Pulmonary Embolism | 3.7% |  
											| Syncope | 3.7% |  
											| Toxicity To Various Agents | 3.7% |  |